Paraventricular nucleus injections of naloxone methiodide inhibit NPY's effects on energy substrate utilization.
Microinjection of neuropeptide Y (NPY) into the paraventricular nucleus (PVN) of the hypothalamus stimulates eating and increases respiratory quotient. In contrast, administration of opioid receptor antagonists reduces food intake and suppresses NPY-induced feeding. The present study examined whether naloxone methiodide, an opioid antagonist, would suppress the potentiation of NPY on energy substrate utilization, when injected into the PVN. Naloxone methiodide was injected at doses of 0.1 and 1.0 g, 10 min prior to NPY treatment. NPY was administered immediately prior to the start of the nocturnal period and RQ was determined using an open-circuit calorimeter. Doses of 50 and 100 pmol NPY alone evoked reliable increases in RQ within 30min of treatment. Following naloxone methiodide pretreatment, the stimulatory action of NPY was significantly attenuated. These data indicate that opioid receptors in the PVN influence the action of NPY on energy substrate utilization.
Currie
P J
PJ
Department of Psychology, Barnard College, Columbia University, New York, NY 10027, USA.
Coscina
D V
DV
Moretti
J
J
Avellino
M D
MD
D000818:Animals; D004734:Energy Metabolism / Q000187:drug effects* / Q000502:physiology*; D008297:Male; D009270:Naloxone / Q000031:analogs & derivatives* / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology*; D009478:Neuropeptide Y / Q000187:drug effects* / Q000378:metabolism*; D018847:Opioid Peptides / Q000187:drug effects / Q000378:metabolism; D010286:Paraventricular Hypothalamic Nucleus / Q000187:drug effects* / Q000378:metabolism*; D011659:Pulmonary Gas Exchange / Q000187:drug effects / Q000502:physiology; D000644:Quaternary Ammonium Compounds; D051381:Rats; D017207:Rats, Sprague-Dawley; D011957:Receptors, Opioid / Q000187:drug effects / Q000378:metabolism
D009292:Narcotic Antagonists; D009478:Neuropeptide Y; D018847:Opioid Peptides; D000644:Quaternary Ammonium Compounds; D011957:Receptors, Opioid; D009270:Naloxone; C041269:N-methylnaloxone